Instituto Dara - Dara Institute

Instituto Dara - Dara Institute company information, Employees & Contact Information

Pioneer in intersectoral work on social determinants of health, Dara Institute started by Dr. Vera Cordeiro to break the vicious cycle between poverty and disease, has up to date touched the lives of over 85,000 directly and millions other around the world. Voted #1 in LAC & Brazil, Dara, with its award-winning interdisciplinary methodology, holds the key to one of the direst problems our world faces in addressing the multidimensional facets of poverty. While Brazil is now in many ways a first world country, a large part of its population still faces social vulnerability and multifaceted challenges, putting millions of individuals at huge disadvantage and perpetuating the gap in access to services and opportunities. Over 7% of Brazil’s population had an income level below the international average of US$1.90 PPP per capita per day, with six out of ten children still living in poverty, deprived of access to education, clean water/sanitation, and housing. Strong civil society organizations that have emerged since the late 80’s have been key to birding the gap of endemic inequality and poverty. Dara Institute is a leading example of this. With its focus on the most vulnerable groups, Dara pioneers its cross-sectoral work by putting the families as protagonists in changing their lives, enhancing income generating capacity, reducing hospitalization rates, & improving education, well-being and housing security. With program boasting impressive rates of success, hospitalization dropping 86%, and income generation increasing by 92%, Dara’s methodology has been exported abroad, become a public policy, while the data transformed into a knowledge hub, set up to stimulate dialogue and action among civil society and government organizations. The work of the organization in large part depends on volunteer and partner support, as well as on donations by individuals, private sector actors, foundations, and institutions. Please consider becoming a sup
Looking for a particular Instituto Dara - Dara Institute employee's phone or email?

Instituto Dara - Dara Institute Questions

News

Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study - Frontiers

Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study Frontiers

Uber Technologies, Inc. - Uber and iFood Announce Strategic Partnership in Brazil - Uber Investor Relations

Uber Technologies, Inc. - Uber and iFood Announce Strategic Partnership in Brazil Uber Investor Relations

Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial - Nature

Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial Nature

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma - The New England Journal of Medicine

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma The New England Journal of Medicine

Audley Moore and Dara Abubakari: Mothers of Pan-Africanism - Verite News

Audley Moore and Dara Abubakari: Mothers of Pan-Africanism Verite News

Salvage therapy with “Dara-KDT-P(A)CE” in heavily pretreated, high-risk, proliferative, relapsed/refractory multiple myeloma - Wiley Online Library

Salvage therapy with “Dara-KDT-P(A)CE” in heavily pretreated, high-risk, proliferative, relapsed/refractory multiple myeloma Wiley Online Library

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis - The New England Journal of Medicine

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis The New England Journal of Medicine

Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN | Blood Cancer Journal - Nature

Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN | Blood Cancer Journal Nature

The role of daratumumab in relapsed/refractory CD38 positive acute leukemias—case report on three cases with a literature review - Frontiers

The role of daratumumab in relapsed/refractory CD38 positive acute leukemias—case report on three cases with a literature review Frontiers

Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): an open-label Phase II study - Wiley Online Library

Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): an open-label Phase II study Wiley Online Library

Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk | Blood Cancer Journal - Nature

Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk | Blood Cancer Journal Nature

The Partition Museum at BR Ambedkar University in Delhi pans in on stories of migration and resettlement of immigrants to Delhi - The Hindu

The Partition Museum at BR Ambedkar University in Delhi pans in on stories of migration and resettlement of immigrants to Delhi The Hindu

Projeto X6H dará origem à nova geração do Fiat Punto - Autos Segredos

Projeto X6H dará origem à nova geração do Fiat Punto Autos Segredos

Top Instituto Dara - Dara Institute Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant